Results 91 to 100 of about 261,378 (297)

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Mitochondrial DNA polymorphisms in individuals died from sudden cardiac death

Фундаментальная и клиническая медицина, 2019
Aim. To identify associations of mtDNA polymorphisms with sudden cardiac death.Materials and Methods. DNA was isolated from the cardiac tissue excised during the autopsy from individuals who died from sudden cardiac death (n = 260).
M. V. Golubenko, A. V. Tsepokina, R. R. Salakhov, V. N. Maksimov, A. A. Gurazheva, B. A. Tkhorenko, A. V. Ponasenko   +6 more
doaj   +1 more source

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice [PDF]

, 2017
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited myocardial disease characterized by fibro-fatty replacement of the right ventricular myocardium, and associated with paroxysmal ventricular arrhythmias and sudden cardiac ...
Antoniades, Aquaro, Avella, Bai, Bao, Battipaglia, Beffagna, Bhonsale, Bhonsale, Breithardt, Broch, Burghouwt, Calkins, Camm, Carvajal-Huerta, Chung, Corrado, D'Ascenzi, Dawson, Dechering, Erkapic, Ermakov, Ermakov, Femia, Fontaine, Gerull, Hamid, Hengel, Hoffmayer, Iriyama, Iyer, James, Jiang, Kataoka, Khaji, Kimura, Kirubakaran, Klauke, Leren, Lewis, Li, Liao, Lin, Lopez-Moreno, Mano, Marcus, Maron, Maron, Mayosi, McKenna, McKoy, Merner, Mussigbrodt, Mussigbrodt, Ohno, Opbergen, Peters, Peters, Peters, Philips, Pilichou, Platonov, Protonotarios, Protonotarios, Quarta, Rampazzo, Riele, Riele, Romero, Romero, Ruwald, Saffitz, Santangeli, Saprungruang, Schinkel, Sen-Chowdhry, Sen-Chowdhry, Sen-Chowdhry, Severini, Silvano, Souissi, Steckman, Sultan, Suzuki, Syrris, Taylor, Te Riele, Tiso, Tse, Tse, Tse, Tse, Vite, Wang, Ward, Wei, Weiner, Wichter, Wlodarska, Wu, Xu, Zhurinsky, Zwaag   +102 more
core   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Is it time to loosen the restrictions on athletes with cardiac disorders competing in sport? [PDF]

, 2017
Sudden cardiac death (SCD) in young athletes is a rare and dramatic event. Initial consensus guidelines from 2005 recommend restriction from competitive sports for all athletes with hereditary cardiomyopathies and channelopathies, with very minor ...
Lambiase, P, Mueser, KT, Providência, R, Segal, O, Teixeira, C, Ullstein, A   +5 more
core   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Genetic Aspects of Hereditary Arrhythmogenic Syndromes in Children and Adults

Acta Clinica Croatica, 2017
Recent research has revealed the genetic etiology of a number of heart diseases that cause sudden cardiac death. Lethal channelopathies are of great importance among the genetically determined heart diseases. Their basic characteristics are unpredictable
Vesna Miranović, Snežana Crnogorac
doaj   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

MOLECULAR-GENETICAL MARKERS OF LIPID ABNORMALITIES AND SUDDEN CARDIAC DEATH

Атеросклероз, 2017
Sudden cardiac death is one of main problem of modern medicine. Sudden cardiac death is about 50 % of all cardiac deaths. The main part of people who died of sudden cardiac death didn’t have any cardiac illnesses.
A. A. Ivanova
doaj